WANBURYNSEWANBURY LIMITED· PharmaceuticalsHighNeutral
Announced Mon, 20 Jul · 16:05 IST

USFDA inspection at Tanuku plant ends with Form 483, six observations

Regulatory & Legal View source PDF

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.1%1-day move
₹340.95
prior close
₹328.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-1.3-2.9+2.5-3.1-3.5-2.6-3.7
Up moveDown movePending
AI summary

USFDA conducted a routine cGMP inspection at Wanbury's Tanuku facility in Andhra Pradesh from July 13 to July 17, 2026. At the end of the inspection, the US regulator issued a Form 483 with six observations. The company will respond to these observations within the stipulated timeframe and will keep the stock exchanges informed of any further updates.

Likely market impact

Form 483 is a standard notice flagging procedural gaps, not a ban or import alert. Watch the company's response and any escalation to a warning letter.